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Cell ular retinoic acid - binding proteins (CRABPs) are a fam-
ily of proteins that sp.ecifical.ly .bin~ reti~oic acid (RA) an.d 
have been implicated 111 medlat111g Its action, although their 
exact function is still unknown. Two CRABPs have been 
identified and cloned. CRABP I is present in many tissues 
and cultured cells; CRABP II, first detected in embryonic 
and neonatal skin of rats and chicks, is now recognized as the 
predominant form in human epidermis. Using.a human li,:-
ing skin equivalent model composed of a d~rmls and an epI-
dermis and human cDNAs recently cloned 111 our laboratory, 
we have studied the effects of 10-6 M RA and etretin (ET) on 
the expression of CRABPs under different culture conditions 
intended to favor greater or lesser degrees of epidermal dif-
ferentiation. Total cellular RNA was isolated separately from 
the dermis and epidermis and processed for northern blot 
analysis. At a presumptive physiologic RA concentration, 
only the gene for CRABP II, and not for CRABP I, was 
R etinoids are vitamin A-related compounds that have profound effects on cellular growth and differentia-tion in both normal and malignant tissues [1- 4]. Reti-noic acid (RA), a metabolite of vitamin A, is believed to mediate vitamin A effects at the cellular level [5,6]. 
RA has been shown to regulate the development of the limb bud 
during embryogenesis and to induce differentiation of malignantly 
transformed cells either directly or indirectly through the induction 
of another protein [7]. On the basis of their well-known major 
effects on both normal and diseased skin [8], RA and other retinoids 
also are extensively employed in the treatment of certain dermato-
logic diseases. 
Two families of proteins that specifically bind retinoids have been 
implicated in mediating their action: cellular retinoic acid binding 
proteins (CRABPs) and nuclear RA receptors. The nuclear recep-
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Abbreviations: 
CRABP: cellular retinoic acid-binding protein 
CS: calf serum 
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DMEM: Dulbecco's modified Eagle's medium 
DMSO: dimethylsulfoxide 
EDTA: ethylenediamine tetraacetic acid 
ET: etretin 
RA: retinoic acid 
TPA: 12-0-tetradecanoyl phorbol 13-acetate 
expressed .. CRABP II transcripts were far more abundant on 
a per cell basis in epidermal keratinocytes than in dermal 
fibroblasts under all conditions studied. Epidermal differen-
tiation, stimulated by air exposure of the cultures, tended to 
enhance CRABP II expression, and treatment with pre-
sumptive therapeutic concentrations of the two retinoid 
compounds tended to decrease CRABP II expression. Oppo-
site effects of air exposure and retinoid treatment were ob-
served on steady state levels of mRNA for selected markers of 
epidermal differentiation: involucrin, trans glutaminase, and 
spr I. These results are consistent with earlier work at the 
protein level examining the effect of retinoids on CRABP 
activity and state of differentiation both in vivo and in vitro. 
Thus, the skin equivalent appears to be an excellent model 
system for investigating the role of CRABPs in mediating 
retinoid effects at the cellular and molecular levels. ] Invest 
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tors, a family of at least five proteins, are now thought to serve as 
transacting factors modulating gene transcription [5 - 7]. and their 
role in mediating retinoid effects in tissue is presently under intense 
investigation in many laboratories. Although the role of CRABPs is 
relatively unknown, they have been postulated to serve as a means of 
maintaining a concentration appropriate for differential regulation 
of gene transcription [9] and to function by increasing the availabil-
ity ofRA to the nuclear receptors [10]. The recent finding that the 
synthetic retinoid CD271 affects the behavior of cultured cells com-
pletely lacking CRABP [11] does not mitigate against the impor-
tance of either of these postulated roles for CRABP, but only sug-
gests that retinoids may still act directly on distal portions of the 
mediator pathway, such as retinoic acid receptors, in the absence of 
these modulatory binding proteins. 
Two CRABPs have been identified and cloned. CRABP I is 
found in many tissues and cultured cells [12]; and CRABP II, first 
detected as a minor species accounting for approximately 5% of 
total CRABP in embryonic and neonatal skin of rats and chicken 
and in the adrenal glands of adult rats [12,14 - 16]. is now recog-
nized as the predominant form in human skin [17,18]. Extensive 
amino acid sequence homology has been found between CRABP I 
and CRABP II, and these two proteins were also shown to have 
similar molecular weight (15 kD) and isoelectric point (5 .0). How-
ever, CRABP I and CRABP II are immunologically distinct and 
have different binding affinities for RA [14,16] . The regulation and 
presumably divergent roles of these two CRABPs are unknown. An 
interesting hypothesis is that these two proteins may provide prefer-
ential delivery of specific retinoids to specific nuclear receptors. 
Through their different binding affinities for RA and presumably 
other retinoids, as well as through preferred interaction with differ-
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ent nuclear receptors, the CRABPs might in part explain the differ-
ential effects of the various retinoids . 
The skin is the first human organ to be substantially reconstructed 
in vitro [19]. As in vivo, this sophisticated culture model associates a 
dermis and an epidermis, and places cutaneous cells in an environ-
ment close to that found itl vivo. This simplified skin has three major 
components: fibroblasts and collagen for the dermis, and keratino-
cytes for the epidermis. Using this human living skin equivalent 
model and human cDNAs recently cloned in our laboratory [18], 
we have studied the effects of retinoids on the expression of 
CRABP I and CRABP II genes under different culture conditions 
intended to favor greater or lesser degrees of epidermal differentia-
tion. The skin equivalents are usually grown submerged in medium, 
but differentiation can be promoted by lifting the skin equivalents 
to allow air exposure [20,21] . We have studied the effects ofRA and 
acitretin (or etretin [ET]) , a synthetic derivative effective in the 
treatment of hyper proliferative diseases [8], on epidermal growth in 
the skin equivalent model [22]. In the present study, we report that 
only the gene for CRABP II, and not for CRABP I, is expressed in 
the skin equivalent model; that CRABP II transcripts are found 
predominantly in the epidermis; ~nd that ~RABP II g~ne. expres-
sion is affected by both state of differentiation and retll10ld treat-
ment. RA and ET had similar but not identical effects. 
MATERIALS AND METHODS 
Construction of the Living Skin Equivalent Fibroblast cul-
tures were established from neonatal foreskins explants as previ-
ously described [23] and grown in Dulbecco's modified Eagle's 
medium (DMEM) (Gibco) supplemented with 10% calf serum 
(CS) (Gibco) , 100 IU/ml penicillin, 100 Ilg/ml streptomycin 
(Boehringer), and 2.5 mg/ml amphotericin-B (Gibco) in a 92% 
air/8% CO2 atmosphere at 37°C. 
Dermal equivalents (DE) were constructed with fibroblasts from 
confluent monolayer cultures at third to eighth passage. After de-
tachment with 0.05% trypsin and 0.02% ethylenediamine tetra-
acetic acid (EDTA) (Gibco), the cells were suspended in medium at 
3 .5 X 105 cells/ml. The DE were prepared as previously described 
[24] by mixing 13.8 ml of1.76 X concentrated DMEM with antibi-
otics, 2.7 ml of CS, 9.0 ml of collagen solution (3 mg/ml in 0.01 % 
acetic acid, extracted from rat tail tendons), 1.5 ml of 0.1 N NaOH, 
and 3 ml of the fibroblast suspension. The mixture was poured into 
a bacteriologic 100-mm diameter petri dish and incubated at 37 °C 
in a 92% air /8% CO2 atmosphere. The collagen polymerized imme-
diately and the gel progressively contracted under the influence of 
the fibroblasts with the formation of collagen bundles. Following 
4 - 7 d of incubation, the DE could be epidermalized. 
On the day of epidermalization, the culture medium was re-
moved from the petri dishes to allow the DE to dry partially. Multi-
ple punch biopsies 2 mm in diameter were taken from neonatal 
foreskins, the major part of the dermal component was excised, and 
the epidermal component was fixed to the center of the DE using a 
drop of collagen solution. In each experiment, skin equivalents 
were prepared from a single foreskin and single fibroblast donor 
cultures. 
Twenty milliliters of fresh medium containing 10% CS and anti-
biotics was then added and cultures were kept in a 92% air/8% CO2 
atmosphere at 37 °C. This medium thus contained approximately 
10-9 to 10-10 M RA [25] and a calcium concentration closely corre-
sponding to the itl vivo concentration measured in the subepidermal 
blister fluid (1.6 mM) [22]. 
Retinoid Treatment RA and ET were kindly supplied by Hoff-
mann-LaRoche (Basel, Switzerland). Retinoid stock solutions were 
prepared in dimethylsulfoxide (DMSO) at 6 X 10- 2 M and stored 
under nitrogen, in darkness, at -20°C. The final concentration of 
DMSO used in the culture medium (0.1 %) did not modify epider-
mal growth [22]. All manipulations involving retinoids were per-
formed in subdued light. Every 2 d, the retinoid stock solution was 
fres hly diluted in medium containing 10% CS, and 5 ml of this 
solution was added to the cultures giving a 10-6 M final concentra-
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tion. In addition, the medium was supplemented twice a week with 
20 ng/ml of epidermal growth factor (Collaborative Research), 
8.4 ~g/ml of c?oleragen (Calbiochem), and 0.4 Ilg/ml of hydro-
cortisone (CalblOchem). After 5 d, one set of the cultures were lifted 
to air exposure to promote epidermal differentiation, and the other 
set remained submerged in medium. Whatever the conditions used, 
an epidermis grew out radially from the biopsies and progressively 
covered the DE. After 2 weeks, the epidermis was analyzed. One set 
of the skin equivalents was used to evaluate epidermal growth and 
the other set for gene expression analysis. 
Evaluation of Epidermal Growth The epidermis was sepa-
rated from the dermal substrate by placing a GF/C Whatman filter 
disc on the culture and lifting it up very gently. Epidermis adhered 
to .t~e filter dis~ by capillary action and was then visualized by 
stammg With Nile blue sulfate (Sigma) at a final concentration of 
0.01% for 30 min at 37"C. The epidermal surface area was mea-
sured with a 386 IBM computer using the AIC (analytical imaging 
concept) software program. 
DNA Probes The probes for CRABP I and II were generated in 
our laboratory [18] and were 600-bp fragments of the 3' end of each 
comple~entary . deoxyribonucleic acid (cDNA). The probe for 
hum~ mvolucru~ was a 6.0-kb HindIII-BamHI fragment of a ge-
nomic DNA received from the American Type Culture Collection 
(Rockville, MD) ~ATCC No. 61046) [26]. Other probes were gen-
erated from keratll10cyte RNA as described by Kawasaki [27]. Total 
RN~ (10 Ilg) was reverse transcribed using oligo dT12-18 (Phar-
maCla) as a pmner, 111 a total volume of 20 Ill. A l-Ill aliquot of this 
product was then amplified with 15 pmol each of the forward and 
reverse primers 20 bp in size in a 100 III reaction volume, using 
reagents from the Gene Amp Kit (Perkin Elmer). Primers were 
de~ived from the published sequences for human spr I [28] and 
epidermal transglutanunase [29], selected as markers of epidermal 
differentiation [30-32], and human 28S rRNA [33] , selected as a 
control to verify even loading of the blots. 
Northern Blot Analysis The epidermis was gently separated 
from the dermis by forceps, and total cellular RNA of each com-
partment was isolated either by the cesium chloride procedure [34] 
or by the acid guanidiniumisothiocyanate-phenol_chloroform ex-
traction [35]. The RNA concentration and purity were determined 
by absorption at 260 and 280 nm, respectively. Five micrograms of 
total RNA was then fractionated on 1 % agarose/6% formaldehyde 
gels [36], and transferred to Hybond-N membranes (Amersham) as 
described by Maniatis et al [34]. The nylon membranes were then 
successively hybridized with radiolabeled probes generated from 
100 to 300 ng cDN~ using a 32P_dCTP (New England Nuclear) 
and the ohgonucleotlde-pnmed DNA labeling system (Pharmacia) 
follo:-v!ng the directions of the ~1anufactur.er. The blots were pre-
hybridized f~r 4 to 6 h 111 hybndlzmg solution at 45 ° C, hybridized 
overnight With 5 to 10 X 106 cpm labeled probe at 45°C, and 
washed as deSCribed [37] . Quantification of autoradiographic band 
denSity was performed USl11g an LKB densitometer with manual 
identification of peaks and baseline. 
Statistical Analysis At least three cultures were used for each 
experi.mental cO~1dition and results were analyzed using the analysis 
of vanance for I11dependent measures (two-factor analysis of var-
iance). 
RESULTS 
Epidermal Growth After 2 weeks of culture, the epidermis was 
gently separated from the dermis and stained with Nile blue sulfate 
to visualize t~1e sur~ace area. A~ previously reported [20,21], expo-
sure of the skm eqUivalents to air reduced the epidermal surface area 
(p < 0.001) to 41 % ± 23% (mean ± SD, N = 3) that of control 
cultures g.rown submerged in medium, suggesting that keratino-
cytes proliferate and/or migrate less when exposed to air. Further-
more, the epidermis looked thicker when exposed to air than when 
submerged in medium, suggesting an increased number ofkeratino-
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Figure 1. Effect of retinoids on epidermal surface area. Skin equivalents 
were maintained submerged for 5 d and then exposed to alT. Cultures 
were grown in serum-supplemented medium containing an ~stimated 
physiologic RA concentration of 10- 9 M [25] and treated with el~her 
10- 6 M RA or ET or diluent alone. The epiderrrus from each skin eqUIva-
lent was then transferred to a filter and visualized with Nile blue sulfate 
staining, enabling calculation of the epidermal surfac~ areas by com-
puter-assisted image analysis. Bar, mean ± 5D for duplicate or trtplicate 
cultures in experiments using three different newborn donors. Treated 
cultures were significantly different (p < 0.0001) from the control cul-
tures when RA and ET were pooled in the two-factor analysis of variance 
statistic test. 
cyte layers corresponding to more advanced epidermal differentia-
tion. 
Both the cultures grown submerged in medium and those ex-
posed to air were treated with 10- 6 M RA or ET. ~ treatment 
decreased epidermal surface area to a greater degree 111 submerged 
cultures than did ET (Fig 1). In three expenments, the surface area 
of RA-treated epidermis was decreased to 50% ± 12% of control 
cultures grown submerged in medium and to 46% ± 16% of con-
trol cultures grown air-exposed (Fig 1). The surface area of ET-
treated epidermis was decreased to 51 % ± 14.5% when grown ex-
posed to air and to only 87% ± 21 % when gro~n submerged in 
medium. RA and ET thus exert qualitatively Similar but quantita-
tively different effects on epidermal growth. 
Gene Expression To investigate these RA and ET effects fur-
ther, we examined the ability ofRA and ET to modulate CRABP I 
and CRABP II gene expression. CRABP II message was found to be 
constitutively expressed in the skin equivalent model, whereas no 
expression of CRABP I message was detected in either the dermal 
or epidermal cells. Caco-2 cells, known to express hi gh levels of 
CRABP I message [18], were used as a positive control for the latter 
(data not shown) . The expression of CRABP II was far higher in 
epidermal than 111 dermal RNA (Fig 2). In each of three experi-
ments, CRABP II was barely detectable in most of the dermal RNA 
samples under exposure conditions sufficiently sensitive to detect 
strong CRABP II probe hybridization in epidermal RNA samples. 
In add ition, air exposure of the cultures was found to strongly up-
regulate the level of epidermal CRABP. II transcripts (Figs 2 and 3). 
Epidermal CRABP II was 2.6 ± 0.6 tunes (p < 0.001) higher in 
cultures exposed to air than those grown submerged in medium 
(Fig 3). Treatment with RA or ET was found to down-regulate 
CRABP II gene expression in both submerged and air-exposed cul-
ture conditions (Fi gs 2 and 4). RA treatment sli ghtly reduced the 
epidermal CRABP II mRNA level, to 78% ± 4% of control levels 
in cultures grown submerged in medium and to 57% ± 24% of 
control levels in air-exposed cultures (Fig 4). ET treatment de-
creased the epidermal CRABP II mRNA level to 59% ± 6.4% and 
54% ± 10% of untreated control levels in cultures grown sub-
merged in medium and exposed to air respectively (Fig 4) . 
We then examined the relationship between CRABP II gene 
expression and the degree of epidermal differentiation in the skin 
equivalents. To quantify the degree of differentiation of the newly 
formed epidermis, we measured mRN A levels of involucrin, a pre-
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Figure 2. Expression of CRABP II and differentiation-associated genes 
in a representative experiment. Skin equivalents were grown and treated 
as described in Fig 1. Total cellular RNA was harvested separately from 
both the epidermis and dermis of each skin equivalent and processed for 
Northern blot analysis. Each Northern blot was sequentially hybridized 
with cDNA probes for CRABP 1I, involucrin (INV), transglutaminase 
(TG), spr 1. and the constitutively expressed 285 rRNA to verify even 
loading. CRABP II expression in the dermal samples is minimal compared 
to that in the epidermal samples on the same blot. As expected, there was 
no detectable expression of spr 1, INV, or TG (data not shown) . 
cursor of the cross-linked envelope [30]; epidermal transglutamin-
ase, the enzyme that catalyses the envelope cross-linking [31]; and 
spr I, a small proline-rich protein of unknown function whose ex-
pression is strongly induced during keratinocyte diffentiation both 
irl vitro and in vivo [32]. Involucrin, epidermal transglutarni nase and 
spr I mRNA levels were higher in air-exposed versus submerged 
cultures (Fig 3), consistent with the greater morphologic differen-
tiation of the cultures. Furthermore, the expression of these genes 
was down-regulated by retinoid treatment in both submerged and 
air-exposed culture conditions (Fig 4) . In submerged cultures, RA 
and ET treatment respectively reduced involucrin mRNA levels to 
94% ± 16% and 42% ± 16%, epidermal transglutaminase mRNA 
levels to 20% and 20%, and spr I mRNA levels to 41 % ± 0.7% and 
26% ± 26% (Fig 4) . In air-exposed cultures, RA and ET treatment 
respectively decreased involucrin mRNA levels to 30% ± 4% and 
91 % ± 36%, epidermal transglutaminase to 44% ± 1.6% and 
46% ± 6.9%, and spr I mRNA levels to 47% ± 11 % and 41 % ± 
16% (Fig 4). 
DISCUSSION 
The purpose of this study was to determine the effect of retinoids at 
pharmacologic (therapeutic) concentrations on the expression of 
CRABP genes in a skin equivalent model under culture conditions 
producing greater and lesser degrees of differentiation. Previous 
reports had shown that air exposure of skin equivalents promoted 
epidermal differentiation as judged by basal cell morphology , abun-
dance of keratohyalin and membrane-coating granules, and the in-
duction of the 67-kD keratin [20,21]. We quantified this tendency 
by measurement of epidermal surface area and up-re gulation of 
steady-state mRNA levels for selected differentiation-associated 
proteins (involucrin, epidermal transglutaminase, and spr I) to 
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Figure 3. Effect of air exposure on gene expression. Using densitometry 
analysis, intensity of the bands from Fig 2 was normalized to 285 rRNA 
band intensity and then expressed as the ratio between experimental and 
control cultures X 100. Bar, mean ± SD for duplicate densitometry read-
ings for each of three separate Northern blots prepared from the RNA of 
three separate donors. Air exposure significantly increased the expression 
of genes for CRABP II, involucrin (INV), spr I (p < 0.0001), and transglu-
taminase (TG, p < 0.005) using the two-factor analysis of variance statis-
tic test. 
allow quantitative comparisons for CRABP expression in retinoid-
treated and control systems. We found that only CRABP II was 
expressed; the CRABP II expression was far ~reater in ~pidermal 
than in dermal cells; a greater degree of epIdermal dIfferentIa-
tion was associated with higher steady-state mRNA levels for 
CRABP II; and both retinoids studied comparably and coordinately 
down-regulated the mRNA levels for CRABP II and the three dif-
ferentiation-associated proteins. 
Earlier studies have reported inconsistent faint CRABP I gene 
expression in human skin and in keratinocyte cultures grown on 
3 T3 feeder layers [17,18]. This discrepancy with the present study 
may reflect the fact that melanocytes, which express only CRABP I 
and not CRABP II [38], apparently proliferate relatively less well in 
the skin equivalent system than in epidermal cell culture conditions 
previously employed [39]. Alternatively, the detection threshold for 
CRABP I expression may simply have been higher in the present 
study. 
The skin equivalent culture model offers a convenient means to 
investigate the dermis and the epidermis separately. The predomin-
ent expression of CRABP II in the epidermis confirms at the 
mRNA level results previously reported at the protein level in 
human skin biopsies [40]. Interestingly, no difference in either 
CRABP II mRNA levels or RA binding activity has been demon-
strated between fibroblasts and keratinocytes grown in conven-
tional cul tures. This suggests that dermal-epidermal interactions 
may affect CRABP II gene exrression, j ust as they alter keratino-
eyte responses to retinoids [21 . 
Increased differentiation, obtained by exposing the cultIlres to air, 
enhanced the epidermal CRABP II gene expression. Of note, the 
twO states of epidermal differentiation compared in this study 
("high-calcium" stratified cultures, submerged versus air-exposed) 
are not those conventionally compared ("low-calcium" mono layers 
vs "high-calcium" stratified cultures, both submerged). However, 
our data are generally in agreement with previous work at a protein 
level that increased differentiation in cultured human keratinocytes 
is associated with increased levels of CRABP activity [41]. Further-
more, these same authors have recently found that only more differ-
entiated (high-calcium) keratinocytes express the enzymic activity 
for transformation of retinol to RA [42]. This supports the hypothe-
sis ofYuspa and co-workers that differentiated keratinocytes are the 
predominant target cells for RA [43]. Our data suggest that within 
this population of relatively differentiated cel ls, substantial modula-
tion in retinoid handling is possible. 
Both RA and ET, at a final concentration of 10- 6 M, down-regu-
lated the level of CRABP II transcripts in both submerged and 
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air-exposed cultures . T hus, the approximately thousandfold in-
crease in r~tinoid concentration above the presumably physiologic 
concentratIon m the serum-supplemented basal medium decreases 
expression of the CRABP II message. This is more consistent with a 
role for CRABP II in transporting RA to the nucleus rather than in 
sequestering excess RA in the cytoplasm. Such a down-regulation of 
CRABP II transcrIpts has also been recently demonstrated in con-
ventional h~man fibroblasts and keratinocyte cultures following 
treatment WIth 10-6 M RA [17,18]. However, these results are not 
in agreement with the stimulation of CRABP II gene expression 
described after topical treatment in vivo with 0.1 % RA cream [17] or 
the doubling of CRABP activity as measured by RA binding in 
normal skin during treatment with etretin for 4 weeks [44] . The 
?iscr~pancy might be expl~ined by the presumed differences in phys-
IOlOgiC state of the keratmocytes and fibroblasts in the different 
study conditions; by the possibility that different pre- and post-
treatment RA concentrations are being compared in vivo versus in 
I/ itro; or by the possibility that iI, vivo other cell populations, absent 
from the culture dish, p~rticipate in the retinoid reaction, modulat-
mg RA effects on keratmocytes and fibroblasts. 
The major role played by retinoids in the epidermal differentia-
tion ~rocess has previously been analyzed at the morphologic and 
protem levels [1-4,45]' but relatively little information is available 
regarding the genetic events that underlie these effects. To stIldy the 
effects of RA and ET on differentiation in the skin equivalent 
model, we explored the expression of three genes: involucrin, a 
major ~omponent of the cornified envelope [30]; epidermal trans-
glutammase, the enzyme required to cross-link envelope proteins 
[31]; and .spr I,. the ex~resslOn of which is stimulated at the protein 
level dUrIng dIfferentiatIon induced by calcium or 12-0-tetrade-
canoylphorbol-13-acetate (TPA) [32]. Air exposure of the cultures 
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Figure~. Effect of retinoid treatment on gene expression in submerged 
versus aIr-exposed cultures. Skin equivalents were prepared for Northern 
blot analysis in three separate experiments as described for Fig 2. RA and 
ET comparably reduced mRNA levels of CRABP 11, involucrin (INV), 
spr I (p < 0.0001), and transglutaminase (TG, p < 0.005) in both sub-
merged and air-exposed cultures, involucrin being the most variable of 
the markers studied. 
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modestly increased mRNA levels of involucrin, epidermal trans-
glutaminase, and spr 1. Although these chang~s are les~ than ~e­
ported by our laboratory and others during keratmocyte dIfferentIa-
tion induced by calcIUm or TPA [32,46,47], as noted above, t~e 
previous comparisons are between minimally and moderately dif-
ferentiated cells, and the present compansons are between moder-
ately and greater than moderately differentiat~d. cells. 
RA and ET have found different cltmcal Utlltty [8], presumably 
reflecting in part their preferential effects on various aspects of 
keratinocyte growth and differentiation programs. In. the present 
study, RA decreased epidermal surface area by appr?xlmately half 
under both submerged and air-exposed culture condltlOn~, whereas 
ET had no significant effect in submerged cultures. PrevIOUS work 
has shown that, at least in submerged cultures, the RA effect IS due 
to the inhibition ofkeratinocyte proliferation, rather than, for exam-
ple, cell migration,.in that DNA content and 3H-thymi~ine incorpo-
ration are proportIOnately decreased by RA [22]. Wlth regard to 
their effects on mRNA levels for CRABP II and the selected differ-
entiation markers, only involucrin appeared to be differently modu-
lated by RA versus ET. Witl:in? weeks, RA markedly down-regu-
lated involucrin expressIOn 111 air-exposed cultures, but had only a 
slight and insignificant effect in submerged cultures,. whereas ET 
had the reverse effect. Previous work has shown no stnklllg change 
in the amount or distribution of involucrin protein as measured by 
immunofluorescent cytochemistry in RA-treated air-exposed cul-
tures [45], but few other pertinent data are avai lable. In particular, it 
is not known whether the effects of retinoids on CRABP II, involu-
crin, transglutaminase, and spr I are direct or indirect, or whether all 
retinoids act through a common final pathway. . 
In conclusion, only the gene for CRABP II, and not CRABP I, IS 
expressed in the human skin equi~alent;. and C~P Il.transcripts 
are found predominantly in the epld~r~ls, ~hlch IS consistent :""Ith 
the recognized major role for ~etmOld.s ~n modulatlllg epider-
mal differentiation. Increased differentiation tends to enhance 
CRABP II expression and retinoid treatment tends to decrease. it. 
The skin equivalent seems an excellent model system for quantita-
tive studies of retinoid effects at a cellular and molecular level. 
Moreover, our results provide additio.nal. supP?rt ~or the postul.ated 
key role of CRABP in mediating retlllOid actIOn 111 human skill. 
This work was supported by tlte USDA Agricultural Research Service arid a follow-
s/lip from the FOlldatiol1 pour la Recherche Medicale ill Frallce awarded to 
Dr. SOllqllcr. 
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MEETING ANNOUNCEMENT 
The Workshop on the Epidemiology of Skin Diseases will be held March 25 - 26, 1993 at 
National Institutes of Health, Building 31, Conference Room 10,9000 Rockville Pike, Be-
thesda, Maryland. 
Objectives will be to present attendants with a current overview of the present status of 
epidemiological research into skin diseases, including but not limited to chronic cutaneous 
ulcers, dermatologic aspects of HI V infection, ichthyosis, non-melanoma skin cancer, psoriasis, 
and toxic epidermalnecrolysis; to identify areas in which epidemiological studies could advance 
the understanding, management, and prevention of skin diseases; and to encourage more 
research into the epidemiology of skin diseases. 
Potential participants include dermatologists and epidemiologists with an interest in skin 
diseases. 
The Planning Committee is comprised of Robert S. Stern, M.D., H arvard Medical School, 
Boston, M assachusetts; Martin A. Weinstock, M.D. , Ph.D., VA Medical Center, Providence, 
Rhode Island; David W . Kaufman, Sc.D., Boston University School of Medicine, Massachu-
setts; Kayvon H. Safavi, M.D., M.P.H., St. Luke's Medical Center, Milwaukee, Wisconsin; 
Alan Moshell , M.D., National Institute of Arthritis and Musculoskeletal and Skin Diseases, 
Bethesda, Maryland; and Reva C. Lawrence, M .P.H., N ational Institute of Arthritis and Muscu-
loskeletal and Skin Diseases, Bethesda, Maryland. 
The workshop is sponsored by the N ational Institute of Arthritis and Musculoskeleta l and 
Skin Diseases (NIAMS) . 
For information and pre-registration call Suzanne Sangalan at (301) 496-0803. 
